Cargando…

Clinical characterization of children and adolescents with NF1 microdeletions

PURPOSE: An estimated 5–11% of patients with neurofibromatosis type 1 (NF1) harbour NF1 microdeletions encompassing the NF1 gene and its flanking regions. The purpose of this study was to evaluate the clinical phenotype in children and adolescents with NF1 microdeletions. METHODS: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kehrer-Sawatzki, Hildegard, Kluwe, Lan, Salamon, Johannes, Well, Lennart, Farschtschi, Said, Rosenbaum, Thorsten, Mautner, Victor-Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Annual Issue Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575500/ https://www.ncbi.nlm.nih.gov/pubmed/32533297 http://dx.doi.org/10.1007/s00381-020-04717-0

Ejemplares similares

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions
por: Mußotter, Tanja, et al.
Publicado: (2012)

Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021)

Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2016)

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality
por: Gugel, Isabel, et al.
Publicado: (2020)

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
por: Well, Lennart, et al.
Publicado: (2020)

Emerging genotype–phenotype relationships in patients with large NF1 deletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2017)

Presenting symptoms in children with neurofibromatosis type 2
por: Gugel, Isabel, et al.
Publicado: (2020)

Identification of an NF1 Microdeletion with Optical Genome Mapping
por: Büki, Gergely, et al.
Publicado: (2023)

Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports
por: Vogt, Julia, et al.
Publicado: (2011)

Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Co‐occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1
por: Kehrer‐Sawatzki, Hildegard, et al.
Publicado: (2018)

Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)
por: Avanesov, Maxim, et al.
Publicado: (2021)

Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome
por: Toledano-Alhadef, Hagit, et al.
Publicado: (2020)

Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses
por: Zipfel, Julian, et al.
Publicado: (2020)

Distinct sequence features underlie microdeletions and gross deletions in the human genome
por: Qi, Mengling, et al.
Publicado: (2022)

Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
por: Ristow, Inka, et al.
Publicado: (2022)

Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
por: Farschtschi, Said, et al.
Publicado: (2020)

Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients
por: Lammert, Marge, et al.
Publicado: (2005)

Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease
por: Martin, Enrico, et al.
Publicado: (2020)

Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1)
por: Mladenov, Kiril V., et al.
Publicado: (2020)

MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
por: Kollmann, Philipp, et al.
Publicado: (2020)

Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
por: Farschtschi, Said, et al.
Publicado: (2016)

Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis
por: Farschtschi, Said C., et al.
Publicado: (2019)

Exploring the potential relevance of human-specific genes to complex disease
por: Cooper, David N, et al.
Publicado: (2011)

C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis
por: Farschtschi, Said C., et al.
Publicado: (2020)

SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints
por: Vogt, Julia, et al.
Publicado: (2014)

Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults
por: Gugel, Isabel, et al.
Publicado: (2018)

A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics
por: Rekate, Harold L.
Publicado: (2011)

Metopic synostosis
por: van der Meulen, Jacques
Publicado: (2012)

The medical autopsy as quality assurance tool in clinical medicine: dreams and realities
por: van den Tweel, Jan G., et al.
Publicado: (2015)

Quality assurance in postgraduate pathology training the Dutch way: regular assessment, monitoring of training programs but no end of training examination
por: van der Valk, Paul
Publicado: (2016)

Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
por: Vyberg, Mogens, et al.
Publicado: (2015)

Surgical approaches for brainstem tumors in pediatric patients
por: Cavalheiro, Sergio, et al.
Publicado: (2015)

Cerebellopontine angle tumors in infants and children
por: Tomita, Tadanori, et al.
Publicado: (2015)

Decompressive craniectomy for traumatic intracranial hypertension: application in children
por: Young, Adam M. H., et al.
Publicado: (2017)

Analgosedation in paediatric severe traumatic brain injury (TBI): practice, pitfalls and possibilities
por: Ketharanathan, N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o2os2suur9oe247jf2riugag83